2017
DOI: 10.1073/pnas.1705407114
|View full text |Cite
|
Sign up to set email alerts
|

Protein nanocages that penetrate airway mucus and tumor tissue

Abstract: Reports on drug delivery systems capable of overcoming multiple biological barriers are rare. We introduce a nanoparticle-based drug delivery technology capable of rapidly penetrating both lung tumor tissue and the mucus layer that protects airway tissues from nanoscale objects. Specifically, human ferritin heavy-chain nanocages (FTn) were functionalized with polyethylene glycol (PEG) in a unique manner that allows robust control over PEG location (nanoparticle surface only) and surface density. We varied PEG … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
100
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
8
2

Relationship

3
7

Authors

Journals

citations
Cited by 109 publications
(103 citation statements)
references
References 52 publications
(63 reference statements)
3
100
0
Order By: Relevance
“…Recent concerns about possible non-specific interactions of iRGD that might reduce the target accumulation of NCs could be overcome by triggering the penetrating peptide exposure in the TME following specific stimuli [49]. Another common approach to minimize the interaction between NCs and the ECM is surface PEGylation, as has been demonstrated in different tumor models, such as orthotopic brain and lung cancers [50,51]. However, a dense PEG layer may discourage interaction with target cells.…”
Section: Tumor-specific Accumulationmentioning
confidence: 99%
“…Recent concerns about possible non-specific interactions of iRGD that might reduce the target accumulation of NCs could be overcome by triggering the penetrating peptide exposure in the TME following specific stimuli [49]. Another common approach to minimize the interaction between NCs and the ECM is surface PEGylation, as has been demonstrated in different tumor models, such as orthotopic brain and lung cancers [50,51]. However, a dense PEG layer may discourage interaction with target cells.…”
Section: Tumor-specific Accumulationmentioning
confidence: 99%
“…This IA-based extension of RH, if successful, would demonstrate the synergistic power of combining nanomedicine with different size-scale technologies; here, we employed the synergistic combination of “nano-micro-macro”: nano-scale drug carriers + micro-scale RBCs + macro-scale IA catheters. The synergy of nano-micro-macro has recently been productively leveraged for other NC and gene therapy delivery challenges, such as intraperitoneally injected NCs that stick to mesothelial cells to act as a drug depot 15 , peri-nerve injections of NCs to block pain 16 , intratracheally administered NCs that localize near airway epithelial cells 17 , 18 , NCs injected into the brain parenchyma to land on neurons or tumor cells 19 21 , and delivery of gene therapy vehicles to overcome similar barriers 22 , 23 . Building off these prior approaches, the particular nano-micro-macro synergy of RH, if successful, could provide localized, high-concentration drug delivery to any organ into which an intravascular catheter can be clinically deployed.…”
Section: Introductionmentioning
confidence: 99%
“…Protein-cage molecules based on the H-chain of human ferritin (HFt) have been recently attracting growing interest in the field of cancer drug delivery, due to their excellent biocompatibility, selectivity for cancer over normal cells, binding to a large number of different human tumors and ability to encapsulate in their internal cavity high amounts (20–120 molecules) of different drug classes [ 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 ]. The cage-like shape is due to the fact that HFt is a multimeric protein consisting of 24 identical subunits that self-assembly into a symmetric hollow sphere, with external and internal diameters of 12 and 8 nm, respectively [ 15 , 16 , 17 , 18 ].…”
Section: Introductionmentioning
confidence: 99%